J. Ludwig, T. Viggiano, D. Mcgill, and B. Oh, Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease, Mayo Clin Proc, vol.55, pp.434-438, 1980.

M. Haque and A. Sanyal, The metabolic abnormalities associated with non-alcoholic fatty liver disease, Best Practice & Research Clinical Gastroenterology, vol.16, issue.5, pp.709-731, 2002.
DOI : 10.1053/bega.2002.0325

C. Day and O. James, Steatohepatitis: A tale of two ???hits????, Gastroenterology, vol.114, issue.4, pp.842-845, 1998.
DOI : 10.1016/S0016-5085(98)70599-2

C. Larter and G. Farrell, Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?, Journal of Hepatology, vol.44, issue.2, pp.253-261, 2006.
DOI : 10.1016/j.jhep.2005.11.030

G. Hotamisligil, The role of TNF?? and TNF receptors in obesity and insulin resistance, Journal of Internal Medicine, vol.100, issue.11, pp.621-625, 1999.
DOI : 10.1046/j.1365-2796.1999.00490.x

M. Yin, M. Wheeler, H. Kono, B. Bradford, and R. Gallucci, Essential role of tumor necrosis factor ?? in alcohol-induced liver injury in mice, Gastroenterology, vol.117, issue.4, pp.942-952, 1999.
DOI : 10.1016/S0016-5085(99)70354-9

J. Crespo, A. Cayon, P. Fernandez-gil, M. Hernandez-guerra, and M. Mayorga, Gene expression of tumor necrosis factor [alpha ] and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients, Hepatology, vol.34, issue.6, pp.1158-1163, 2001.
DOI : 10.1053/jhep.2001.29628

I. Bahcecioglu, M. Yalniz, H. Ataseven, N. Ilhan, and I. Ozercan, Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis, Hepatogastroenterology, vol.52, pp.1549-53, 2005.

R. Memon, C. Grunfeld, and K. Feingold, TNF-alpha is not the cause of fatty liver disease in obese diabetic mice, Nature Medicine, vol.7, issue.1, pp.2-3, 2001.
DOI : 10.1038/83316

Q. Deng, H. She, J. Cheng, S. French, and D. Koop, Steatohepatitis induced by intragastric overfeeding in mice, Hepatology, vol.47, issue.4, pp.905-914, 2005.
DOI : 10.1002/hep.20877

A. Feldstein, N. Werneburg, A. Canbay, M. Guicciardi, and S. Bronk, O0040 FREE FATTY ACIDS PROMOTE HEPATIC LIPOTOXICITY BY STIMULATING TNF-ALPHA EXPRESSION VIA A LYSOSOMAL PATHWAY, Journal of Pediatric Gastroenterology and Nutrition, vol.39, issue.Supplement 1, pp.185-194, 2004.
DOI : 10.1097/00005176-200406001-00042

K. Tomita, G. Tamiya, S. Ando, K. Oshumi, and T. Chiyo, Tumour necrosis factor ?? signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice, Gut, vol.55, issue.3, pp.415-424, 2006.
DOI : 10.1136/gut.2005.071118

R. Mccuskey, Y. Ito, G. Robertson, M. Mccuskey, and M. Perry, Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice, Hepatology, vol.266, issue.2, pp.386-93, 2004.
DOI : 10.1002/hep.20302

M. Rinella and R. Green, The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance, Journal of Hepatology, vol.40, issue.1, pp.47-51, 2004.
DOI : 10.1016/j.jhep.2003.09.020

A. Diehl, Lessons from animal models of NASH, Hepatology Research, vol.33, issue.2, pp.138-144, 2005.
DOI : 10.1016/j.hepres.2005.09.022

Z. Yao and D. Vance, The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes, J Biol Chem, vol.263, pp.2998-3004, 1988.

M. Rinella, M. Elias, R. Smolak, T. Fu, and J. Borensztajn, Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet, The Journal of Lipid Research, vol.49, issue.5, pp.1068-1076, 2008.
DOI : 10.1194/jlr.M800042-JLR200

M. Kopf, H. Baumann, G. Freer, M. Freudenberg, and M. Lamers, Impaired immune and acute-phase responses in interleukin-6-deficient mice, Nature, vol.368, issue.6469, pp.339-342, 1994.
DOI : 10.1038/368339a0

E. Brunt, C. Janney, D. Bisceglie, A. Neuschwander-tetri, B. Bacon et al., Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, The American Journal of Gastroenterology, vol.10, issue.9, pp.2467-2474, 1999.
DOI : 10.1016/S0168-8278(96)80234-0

D. Kleiner, E. Brunt, M. Van-natta, C. Behling, and M. Contos, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, vol.38, issue.6, pp.1313-1321, 2005.
DOI : 10.1002/hep.20701

M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Analytical Biochemistry, vol.72, issue.1-2, pp.248-254, 1976.
DOI : 10.1016/0003-2697(76)90527-3

J. Folch, M. Lees, S. Stanley, and G. , A simple method for the isolation and purification of total lipides from animal tissues, J Biol Chem, vol.226, pp.497-509, 1957.

B. Ames, [10] Assay of inorganic phosphate, total phosphate and phosphatases, Meth Enzymol, vol.8, pp.115-118, 1966.
DOI : 10.1016/0076-6879(66)08014-5

A. Bielawska, D. Perry, and Y. Hannun, Determination of Ceramides and Diglycerides by the Diglyceride Kinase Assay, Analytical Biochemistry, vol.298, issue.2, pp.141-150, 2001.
DOI : 10.1006/abio.2001.5342

J. George, N. Pera, N. Phung, I. Leclercq, Y. Hou et al., Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis, Journal of Hepatology, vol.39, issue.5, pp.756-764, 2003.
DOI : 10.1016/S0168-8278(03)00376-3

O. Cuvillier, L. Edsall, and S. Spiegel, Involvement of Sphingosine in Mitochondria-dependent Fas-induced Apoptosis of Type II Jurkat T Cells, Journal of Biological Chemistry, vol.275, issue.21, pp.15691-15700, 2000.
DOI : 10.1074/jbc.M000280200

S. Natori, C. Rust, L. Stadheim, A. Srinivasan, and L. Burgart, Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis, Journal of Hepatology, vol.34, issue.2, pp.248-253, 2001.
DOI : 10.1016/S0168-8278(00)00089-1

A. Feldstein, A. Canbay, P. Angulo, M. Taniai, and L. Burgart, Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis, Gastroenterology, vol.125, issue.2, pp.437-443, 2003.
DOI : 10.1016/S0016-5085(03)00907-7

P. Ribeiro, H. Cortez-pinto, S. Sola, R. Castro, and R. Ramalho, Hepatocyte apoptosis, expression of death receptors, and activation of NFkappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients, 2004.

X. Jin, T. Zimmers, E. Perez, R. Pierce, and Z. Zhang, Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair, Hepatology, vol.107, issue.3, pp.474-484, 2006.
DOI : 10.1002/hep.21087

R. Kirsch, V. Clarkson, R. Verdonk, A. Marais, and E. Shepard, Rodent nutritional model of steatohepatitis: Effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency, Journal of Gastroenterology and Hepatology, vol.105, issue.1, pp.174-182, 2006.
DOI : 10.1111/j.1440-1746.2005.04220.x

J. Baumgardner, K. Shankar, L. Hennings, T. Badger, and M. Ronis, A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet, AJP: Gastrointestinal and Liver Physiology, vol.294, issue.1, pp.27-38, 2007.
DOI : 10.1152/ajpgi.00296.2007

Z. Li, L. Agellon, T. Allen, M. Umeda, and L. Jewell, The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis, Cell Metabolism, vol.3, issue.5, pp.321-331, 2006.
DOI : 10.1016/j.cmet.2006.03.007

P. Puri, R. Baillie, M. Wiest, F. Mirshahi, and J. Choudhury, A lipidomic analysis of nonalcoholic fatty liver disease, Hepatology, vol.343, issue.4, pp.1081-1090, 2007.
DOI : 10.1002/hep.21763

W. Holland, J. Brozinick, L. Wang, E. Hawkins, and K. Sargent, Inhibition of Ceramide Synthesis Ameliorates Glucocorticoid-, Saturated-Fat-, and Obesity-Induced Insulin Resistance, Cell Metabolism, vol.5, issue.3, pp.167-179, 2007.
DOI : 10.1016/j.cmet.2007.01.002

M. Mari and J. Fernandez-checa, Sphingolipid signalling and liver diseases, Liver International, vol.18, issue.5, pp.440-450, 2007.
DOI : 10.1093/qjmed/93.4.237

S. Malagarie-cazenave, N. Andrieu-abadie, B. Ségui, V. Gouaz, and C. Tardy, Sphingolipid signalling: molecular basis and role in TNF-[alpha]-induced cell death, Expert Reviews in Molecular Medicine, vol.4, issue.28, pp.1-15, 2002.
DOI : 10.1017/S146239940200546X

S. Malagarie-cazenave, B. Ségui, S. Leveque, V. Garcia, and S. Carpentier, Role of FAN in Tumor Necrosis Factor-?? and Lipopolysaccharide-induced Interleukin-6 Secretion and Lethality in D-Galactosamine-sensitized Mice, Journal of Biological Chemistry, vol.279, issue.18, pp.18648-18655, 2004.
DOI : 10.1074/jbc.M314294200

I. Leclercq, G. Farrell, J. Field, D. Bell, and F. Gonzalez, CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis, Journal of Clinical Investigation, vol.105, issue.8, pp.1067-1075, 2000.
DOI : 10.1172/JCI8814

D. Pena, A. Leclercq, I. Field, J. George, J. Jones et al., NF-??B Activation, Rather Than TNF, Mediates Hepatic Inflammation in a Murine Dietary Model of Steatohepatitis, Gastroenterology, vol.129, issue.5, pp.1663-1674, 2005.
DOI : 10.1053/j.gastro.2005.09.004

M. Gyamfi, I. Damjanov, S. French, and Y. Wan, The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury, Biochemical Pharmacology, vol.75, issue.4, pp.981-995, 2008.
DOI : 10.1016/j.bcp.2007.09.030

V. Wallenius, K. Wallenius, B. Ahren, M. Rudling, and H. Carlsten, Interleukin-6-deficient mice develop mature-onset obesity, Nature Medicine, vol.8, issue.1, pp.75-79, 2002.
DOI : 10.1038/nm0102-75

J. Senn, P. Klover, I. Nowak, and R. Mooney, Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes, Diabetes, vol.51, issue.12, pp.3391-3399, 2002.
DOI : 10.2337/diabetes.51.12.3391

S. Abiru, K. Migita, Y. Maeda, M. Daikoku, and M. Ito, Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis, Liver International, vol.1592, issue.1, pp.39-45, 2006.
DOI : 10.1111/j.1478-3231.2005.01191.x

J. Haukeland, J. Damas, Z. Konopski, E. Loberg, and T. Haaland, Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2, Journal of Hepatology, vol.44, issue.6, pp.1167-1174, 2006.
DOI : 10.1016/j.jhep.2006.02.011

D. Hill, L. Marsano, D. Cohen, A. J. Shedlofsky, and S. , Increased plasma interleukin-8 concentrations in alcoholic hepatitis, Hepatology, vol.72, issue.3, pp.547-552, 1992.
DOI : 10.1002/hep.1840180316

B. Pedersen and C. Fischer, Physiological roles of muscle-derived interleukin-6 in response to exercise, Current Opinion in Clinical Nutrition and Metabolic Care, vol.10, issue.3, pp.265-271, 2007.
DOI : 10.1097/MCO.0b013e3280ebb5b3

DOI : 10.1152/japplphysiol.01208a.2006

B. Pedersen and M. Febbraio, Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis, Journal of Applied Physiology, vol.102, issue.2, pp.814-816, 2007.
DOI : 10.1152/japplphysiol.01208.2006

D. Cressman, L. Greenbaum, R. Deangelis, G. Ciliberto, and E. Furth, Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice, Science, vol.274, issue.5291, pp.1379-1383, 1996.
DOI : 10.1126/science.274.5291.1379

C. Deutschman, M. Cereda, E. Ochroch, and N. Raj, Sepsis-induced cholestasis, steatosis, hepatocellular injury, and impaired hepatocellular regeneration are enhanced in interleukin-6 ???/??? mice*, Critical Care Medicine, vol.34, issue.10, pp.2613-2620, 2006.
DOI : 10.1097/01.CCM.0000240229.98275.07

F. Hong, S. Radaeva, H. Pan, Z. Tian, and R. Veech, Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease, Hepatology, vol.36, issue.4, pp.933-941, 2004.
DOI : 10.1002/hep.20400

F. Hong, W. Kim, Z. Tian, . Jaruga, and E. Ishac, Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-xL proteins, Oncogene, vol.431, issue.1, pp.32-43, 2002.
DOI : 10.1038/sj.onc.1205016

O. El-assal, F. Hong, W. Kim, S. Radaeva, and B. Gao, IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanolinduced oxidative stress and mitochondrial permeability transition in the liver, Cell Mol Immunol, vol.1, pp.205-211, 2004.

H. Mcgettrick, E. Smith, A. Filer, S. Kissane, and M. Salmon, Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells, European Journal of Immunology, vol.179, issue.1, pp.113-125, 2009.
DOI : 10.1002/eji.200838232

J. Kim, R. Bachmann, and J. Chen, Chapter 21 Interleukin???6 and Insulin Resistance, Vitam Horm, vol.80, pp.613-633, 2009.
DOI : 10.1016/S0083-6729(08)00621-3

T. Korn, E. Betteli, M. Oukka, and V. Kuchroo, IL-17 and Th17 Cells, Annual Review of Immunology, vol.27, issue.1, pp.485-517, 2009.
DOI : 10.1146/annurev.immunol.021908.132710

J. Scheller, R. , and S. , Interleukin-6 and its receptor: from bench to bedside, Medical Microbiology and Immunology, vol.275, issue.4, pp.173-183, 2006.
DOI : 10.1007/s00430-006-0019-9

J. Fernandez-checa, A. Colell, M. Mari, and C. Garcia-ruiz, Ceramide, Tumor Necrosis Factor and Alcohol-Induced Liver Disease, Alcoholism: Clinical & Experimental Research, vol.2, issue.Supplement, pp.151-157, 2005.
DOI : 10.1053/jhep.2002.34943

A. Wieckowska, B. Papouchado, Z. Li, R. Lopez, and N. Zein, Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis, The American Journal of Gastroenterology, vol.127, issue.2, pp.1372-1379, 2008.
DOI : 10.1210/jc.82.12.4196